Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Intravenous Immunoglobulin for Treating Sepsis, Severe Sepsis and Septic Shock." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431416/all/Sublingual_immunotherapy_for_allergic_rhinitis:_Cochrane_systematic_review. Accessed 26 April 2024.
Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431416/all/Sublingual_immunotherapy_for_allergic_rhinitis:_Cochrane_systematic_review. Accessed April 26, 2024.
Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/431416/all/Sublingual_immunotherapy_for_allergic_rhinitis:_Cochrane_systematic_review
Intravenous Immunoglobulin for Treating Sepsis, Severe Sepsis and Septic Shock [Internet]. In: Cochrane Abstracts. [cited 2024 April 26]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431416/all/Sublingual_immunotherapy_for_allergic_rhinitis:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock
ID - 431416
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431416/all/Sublingual_immunotherapy_for_allergic_rhinitis:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -